| Device |
system, cystic fibrosis transmembrane conductance regulator, gene mutation detection |
| Regulation Description |
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation detection system. |
| Definition |
The cftr gene mutation detection system is a device used to simultaneously detect and identify a panel of mutations and variants in the cftr gene. It is intended as an aid in confirmatory diagnostic testing of individuals with suspected cystic fibrosis (cf), carrier identification, and newborn screening. This device is not intended for stand-alone diagnostic purposes, prenatal diagnostic, pre-implantation or population screening. |
| Physical State |
Multiplex qualitative amplification based detection system. Should not include devices which use sequencing based detection methods. |
| Technical Method |
Uses multiplex polymerase chain reaction to amplify specific DNA variants located on the CFTR gene using non-sequencing based methods. |
| Target Area |
Human peripheral whole blood or clinical samples. |
| Regulation Medical Specialty |
Immunology |
| Review Panel |
Pathology |
|---|
| Product Code | NUA |
|---|
| Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Molecular Genetics and Pathology
(DMGP)
|
| Submission Type |
510(k)
|
|---|
| Regulation Number |
866.5900
|
|---|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction
Reporting |
Eligible |
| Implanted Device? |
No
|
|---|
| Life-Sustain/Support Device? |
No
|
|---|
| Guidance Document
|
| Third Party Review |
Not Third Party Eligible |
